NEW YORK, Jan. 12 /PRNewswire-USNewswire/ -- Innovations at the
intersection of medicine, biotechnology, engineering, physical sciences and
information technology are spurring new directions in R&D,
commercialization and technology transfer. Basic research in nanomedicine
and bionanotechnology is rapidly producing commercially viable products.
Governments and industries across the globe are staking their claims by
investing billions for research. Clearly, international rivalries are
growing and political alliances and battle lines are beginning to gel.
The nanotech community will gather at ALM's Strategic Research
Institute's "2nd Annual NANOMEDICINE: Commercializing Drug Delivery,
Diagnostics and Medical Devices" conference for two days on March 26-27,
2007 in Arlington, VA to discuss the most important applications of
nanotechnology in drug delivery, diagnostics and medical devices. The
two-day event will consist of presentations, panels and networking
opportunities, providing insights into trends in nanomedicine, dissociating
myths from realities and highlighting future areas of commercial potential.
The previous conference was so successful that a front-page lead cover
story covering the conference appeared in Genetic Engineering News.
The 2007 event will focus on cutting-edge R&D, commercialization
strategies, policy, regulatory and IP issues -- offering networking
opportunities to researchers from industry, government and academia;
physicians; intellectual property practitioners; business and economic
development professionals; technology transfer specialists, policy makers
and venture capitalists.
For more information on registration, potential speaking engagements,
or sponsorship/exhibition opportunities, please contact the organizer, Jon
E. Liong of Strategic Research Institute at firstname.lastname@example.org or call
(212)967-0095 ext. 243. The conference website is www.srinstitute.com/nano.
ABOUT STRATEGIC RESEARCH INSTITUTE
The Strategic Research Institute is part of ALM's Conference and Trade
Show Division, one of North America's largest producers of educational and
networking events for business leaders and the legal profession. The
division offers more than 300 conferences and two leading industry
tradeshows, as well as conferences in Europe and Asia. Attendance at the
division's events, which span a broad range of topics including law,
finance, natural resources, life sciences, multi-cultural marketing, real
estate and healthcare, will exceed 40,000 executive-level decision makers
Headquartered in New York City, ALM is a leading integrated media
company, focused on the legal and business communities. ALM currently owns
and publishes 37 national and regional magazines and newspapers, including
The American Lawyer(R), Corporate Counsel(R), The National Law Journal(R)
and Real Estate Forum(R). Other ALM businesses include Law.com(R), the
Web's leading legal news and information network, Law Journal Press books,
newsletter publishing, court verdict and settlement reporting, production
of professional educational seminars, market research and content
distribution. ALM was formed by U.S. Equity Partners, L.P., a private
equity fund sponsored by Wasserstein & Co., LP. More information on ALM's
businesses and services is available on the Web at www.alm.com.
SOURCE Strategic Research Institute